BT财经

境内金融信息服务备案编号:

【京金信备(2021)5号】

2024年11月30日

Zhendong PHARMACY 2023 Interim Report: Increase in Operating Revenue, Significant Change in Net Cash Flow

 

"Zhendong PHARMACY (stock code: 300158) is a company of significant standing in the pharmaceutical industry, with its main business encompassing the research and development, production, and sales of generic and innovative drugs, as well as the cultivation and processing of the entire industry chain of traditional Chinese medicine materials. Zhendong PHARMACY has a certain influence in the pharmaceutical industry, being rated as one of the top 100 pharmaceutical manufacturers and ranking among the top in the TOP 100 list of Chinese chemical pharmaceutical companies.



未完......
请加入BT财经数据通会员查看全文!
加入BT财经数据通会员 >>




版权声明:本文版权归BT财经所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

领讯时代文化传媒 | Copyright ©️ 2024 财经时报 版权所有 京ICP备19043396号-7

京公网安备 11010602007380号 | 境内金融信息服务备案编号:京金信备(2021)5号

网信算备110106674807801230011号


声明:未经授权,不得复制、转载或以其他方式使用本网站的内容。BT财经尽最大努力确保数据准确,但不保证数据绝对正确。